One-stop Covid shot gets closer to approval | First Thing

Coronavirus vaccine from Johnson & Johnson safe and effective in trials, the FDA says. Plus, Biden reverses yet more of Trump's executive orders

Good morning.

The one-shot coronavirus vaccine from Johnson & Johnson appears to be safe and effective in trials, the US Food and Drug Administration (FDA) said in documents published yesterday. The vaccine effectively reduced the risk of Covid-19, and prevented confirmed cases of the virus, at least 14 days after vaccination, according to FDA briefing documents. This takes the prospective vaccine a step closer to approval, with an advisory panel of independent experts set to meet on Friday to decide whether to recommend that the FDA take the step.